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Summary
Antenatal Bartter syndrome is a variant of inherited re-
nal-tubular disorders associated with hypokalemic al-
kalosis. This disorder typically presents as a life-threat-
ening condition beginning in utero, with marked fetal
polyuria that leads to polyhydramnios and premature
delivery. Another hallmark of this variant is a marked
hypercalciuria and, as a secondary consequence, the de-
velopment of nephrocalcinosis and osteopenia. We have
analyzed 15 probands belonging to 13 families and have
performed SSCP analysis of the coding sequence and the
exon-intron boundaries of the NKCC2 gene; and we
report 14 novel mutations in patients with antenatal
Bartter syndrome, as well as the identification of three
isoforms of human NKCC2 that arise from alternative
splicing.
Introduction
The antenatal hypercalciuric variant of Bartter syn-
drome, also termed “hyperprostaglandin E syndrome”
(Seyberth et al. 1987), is a rare renal-tubular disorder
that shares common features (hypokalemia, metabolic
alkalosis, and hyperreninemic hyperaldosteronism with
normal blood pressure) with the two other types of Bart-
ter syndrome: the classic variant, originally described by
Bartter et al. (1962), and the hypocalciuric-hypomag-
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nesemic variant, described by Gitelman et al. (1966).
Within this relatively rare set of disorders, familial cases
occur commonly, and inheritance fits best with auto-
somal recessive transmission (Hogewind et al. 1981;
Schwartz and Alon 1996).
In contrast to classic Bartter syndrome and Gitelman
syndrome, the antenatal variant of Bartter syndrome
typically presents as a life-threatening disorder that is
characterized by both renal-tubular hypokalemic alka-
losis and profound systemic manifestations (Seyberth et
al. 1985, 1987). Abnormalities begin in utero, with
marked fetal polyuria that leads to polyhydramnios and
premature delivery (Ohlsson et al. 1984; Proesmans et
al. 1985; Seyberth et al. 1985; Deschenes et al. 1993).
Affected neonates show severe salt wasting and hypos-
thenuria, moderate to severe hypokalemic metabolic al-
kalosis, hyperprostaglandinuria, and failure to thrive.
Another hallmark of this variant is a marked hypercal-
ciuria (always 16 mg/kg/d and often 110 mg/kg/d) and,
as a secondary consequence, the development of ne-
phrocalcinosis and osteopenia (Fanconi et al. 1971;
McCredie et al. 1974; Leonhardt et al. 1992; Shoemaker
et al. 1993).
It has been demonstrated that antenatal Bartter syn-
drome is genetically heterogeneous. Mutations in either
the gene encoding the luminal bumetanide-sensitive Na-
K-2Cl cotransporter (NKCC2) or the gene encoding the
luminal ATP-regulated potassium channel, ROMK
(KCJN1), have been described (Simon et al. 1996a,
1996b; The International Collaborative Study Group for
Bartter-Like Syndromes 1997). Recently, mutations in
the CLCNKB gene, which codes for the basolateral renal
chloride channel, ClC-Kb, were identified in patients
with the severe neonatal phenotype but also in those
with milder forms of Bartter syndrome. The distinguish-
ing feature of this latter group of patients was the ab-
sence of nephrocalcinosis, although hypercalciuria was
present in 11 of 17 cases (Simon et al. 1997). These
genetic data indicate that the molecular pathogenesis of
Vargas-Poussou et al.: NKCC2 and Bartter Syndrome 1333
Table 1
Clinical and Biological Characteristics of Index Patients with Antenatal Bartter Syndrome
Who Were Not Receiving Indomethacin Therapy
Subject
(Gestational Age [wk]) Polyhydramnios
Iso-/
Hyposthenuriaa Hypercalciuriab Nephrocalcinosisc Alkalosisd
Hypokalemia and/or
Elevated eFEK
AB.Paris1 (32)      
AB.Paris3.1 (33)      
AB.Paris3.2 (26)      
AB.Paris8 (32)  ND    
AB.Paris9 (24)      
AB.Marb1 (33)      
AB.Marb6 (32)      
AB.Marb7 (34)  ND    
AB.Marb8 (29)      
AB.Marb9 (30)      
AB.Marb10 (33)      
AB.Marb11 (31)    ND  
AB.Frei1 (unknown)      
AB.Frei2.1 (32)      
AB.Frei2.2 (39)      
NOTE.—A plus sign () denotes presence of the characteristic; ND  not determined.
a Urine osmolality X300 mosmol/kg, with plasma osmolality 1290 mosmol/kg.
b Renal calcium excretion 10.6 mg/mg creatinine, or 16 mg/kg/d.
c Renal sonographic evidence of nephrocalcinosis.
d Serum bicarbonate 126 mmol/liter.
e For hypokalemia, serum potassium !3.3 mmol/liter; and, for elevated , fractional excretion of potassium 115%.FEK
Bartter syndrome involves a defect in one of the mole-
cules primarily or secondarily involved in transepithelial
chloride transport across the thick ascending limb (TAL).
Interestingly, in the NKCC2 genes of rabbit, mouse,
and rat, three isoforms with differential nephron local-
ization have been described. These isoforms differ only
by a single 96-bp fragment (corresponding to exon 4),
which appears to have arisen from alternative splicing
(each variant contains a different version of exon 4)
(Payne and Forbush 1994; Igarashi et al. 1995; Yang et
al. 1996). This 96-bp exon encodes most of the second
transmembrane segment (TM2), which may form part
of the ion-translocation pocket. Differences in TM2 in
the three isoforms may modify ion binding and ion-
affinity determination. Since these isoforms have differ-
ential nephron localization, these data could explain the
differences in transport characteristics of Na-K-2Cl co-
transporters and in regulation of salt transport along the
nephron (Payne and Forbush 1995).
Here, we report several novel mutations in the
NKCC2 gene that are detected in patients with the an-
tenatal variant of Bartter syndrome, and we describe the
characterization of three isoforms of the human NKCC2
gene.
Patients, Material, and Methods
Patients
We analyzed 15 patients with antenatal Bartter syn-
drome who belonged to 13 families (table 1). Index
cases from families AB.Paris1, AB.Paris3, AB.Paris8,
AB.Paris9, AB.Marb1, AB.Marb6, AB.Marb8, and
AB.Marb10 have been reported elsewhere (Wippermann
et al. 1993; Ko¨ckerling et al. 1996; The International
Collaborative Study Group for Bartter-Like Syndromes
1997). The other cases were identified either in neonatal
intensive-care units or in pediatric-nephrology clinics. In
family AB.Paris9, DNA from an affected fetus dead in
utero at 26 wk gestation was also tested. These studies
were approved by local ethics committees, and informed
consent was obtained from the probands’ parents.
Genotype Analysis and Haplotype Construction
By standard methods (Knebelmann et al. 1992), ge-
nomic DNA was extracted from whole blood of all af-
fected individuals and available family members. Hap-
lotyping was performed with NKCC2-linked markers
D15S132, D15S143, D15S123, D15S209, D15S982,
D15S126, and D15S121, as reported elsewhere (The
International Collaborative Study Group for Bartter-
Like Syndromes 1997).
Microsatellite polymorphisms were amplified as de-
scribed elsewhere (The International Collaborative
Study Group for Bartter-Like Syndromes 1997), and am-
plified products were separated on 6% polyacrylamide
gels run under denaturing conditions (Reed et al. 1994).
The gels were either analyzed by use of Genescan 672
software (version 1.2) or visualized by autoradiography.
Haplotypes were constructed on the basis of the geno-
type data. The most likely haplotypes were inferred by
minimizing the number of crossover events in each
sibship.
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Long-Range PCR and Characterization of NKCC2
Isoforms
A human genomic bacterial-artificial-chromosome
(BAC) library (Shizuya et al. 1992) was screened by use
of a 1.1-kb human genomic PCR product (amplified
with primers located in the human NKCC2 cDNA se-
quence [forward primer ATA GGC CTG ATC TTT GCT
TTT and reverse primer GGT CCA CCA TCA TCG
AAT CAC]). Three BACs—30M23, 124I1, and
167E12—were obtained and were shown, by PCR am-
plification, to contain exons 3–5 of the NKCC2 gene.
To determine the sequence of the isoforms of exon 4, a
sense primer was chosen in exon 3 (34 forward [TGC
TCT TCA TTC GCC TCT CC]), and an antisense pri-
mer was chosen in exon 5 (34 reverse [ACT CGG GCC
CTA AAC TTC TG]), of the published sequence (Simon
et al. 1996a). These primers were used to directly am-
plify the DNA from the three BACs, by long-range PCR
(LR-PCR). LR-PCR reactions were performed with the
Expand Long Template PCR System Kit (Boehringer
Mannheim) as described elsewhere (Rozet et al. 1996).
Cycling was performed by use of a Perkin-Elmer
GenAmp 9600 Thermocycler. The product obtained was
purified with a GeneClean Spin Kit (Bio 101), and direct
sequencing was performed by primer walking along the
sequence by use of an Applied Biosystems DNA se-
quencer (model 373A; Perkin-Elmer) and a dideoxy-cy-
cle sequencing protocol (according to the manufacturer’s
instructions) in the presence of specific primers together
with fluorescence-labeled dideoxy terminators.
PCR and SSCP Analysis
The NKCC2 gene was screened for mobility shifts, by
SSCP analysis (Orita et al. 1989). Specific primer pairs
that amplify the splice sites and the 26 exons of this gene
have been described elsewhere (Simon et al. 1996a). Pri-
mer pairs were also chosen to amplify the two additional
isoforms of exon 4 (primer pair 4A forward [GCC CGA
AGC ATG GAC TGA AA] and 4A reverse [ACC CGT
AGC AAG TGA TGA GG] and primer pair 4F forward
[GCC TCC TGA AGT ACT GGT GA] and 4F reverse
[TTT TGT TTA GGA CAC TGG GG], for isoforms A
and F, respectively). PCR reactions were performed in a
25-ml volume containing 50 ng of genomic DNA, 1.5
mM MgCl2, 10 mM Tris (pH 8.3), 50 mM KCl, 10 pmol
of each primer, 0.5 U of Taq polymerase, and 0.8 mCi
of [a[33P]- dCTP. PCR conditions were optimized for the
two additional isoforms: after an initial denaturation
step at 94C for 5 min, PCR was conducted for 30 cycles
of denaturation at 94C for 45 s, annealing at 54C (for
isoform A of exon 4) and 58C (for isoform F of exon
4) for 45 s, and extension at 72C for 45 s. The reaction
was completed with a final elongation step at 72C for
10 min. Amplified products were analyzed for confor-
mational variants, by electrophoresis on a 0.5 # Hy-
drolink mutation-detection–enhancement (MDE) non-
denaturing gel (AT Biochem) at 4C, 25C, or both, in
0.5 # Tris-borate EDTA, at 3–5 W overnight. The gels
were dried and exposed to x-ray film for 48–72 h at
80C. Alternatively, nonradioactive PCR was per-
formed, and gels were silver stained as described else-
where (Hiort et al. 1994). Identified variants were ream-
plified, purified on 1.5% agarose gels, and sequenced
directly, as described above. In all cases, DNA sequences
were confirmed by sequencing of both strands.
Results
Antenatal Bartter Syndrome Kindreds
We analyzed 15 patients and 1 fetus belonging to 13
families. In six families (AB.Marb1, AB.Marb7,
AB.Paris1, AB.Paris8, AB.Paris9, and AB.Frei1), the af-
fected children were from consanguineous unions. In
families AB.Frei2 and AB.Paris3, there were two affected
siblings. All index cases had a history of polyhydramnios
and premature delivery. Postnatally, patients developed
hypokalemic alkalosis, and all had hyposthenuria. Prior
to the initiation of indomethacin therapy, all affected
infants had failed to thrive, with growth parameters at
!3d percentile for their age. Urinary-excretion rates of
prostaglandin E2 (PGE2) and/or its major metabolite,
prostaglandin E-M (PGE-M), were markedly elevated
(100% above upper limit of normal) in all patients in
whom these rates were measured. Hypercalciuria with
associated sonographic evidence of nephrocalcinosis was
demonstrated in all patients. More-detailed clinical fea-
tures of the patients and laboratory data are given in
table 1.
Genotype Analysis
We were able to determine whether the NKCC2 gene
was the disease-susceptibility locus in six families. Mark-
ers tightly linked to the NKCC2 locus on chromosome
15 were typed; for example, in families AB.Paris1,
AB.Paris8, AB.Paris9, and AB.Marb1, affected offspring
of consanguineous unions were homozygous for these
markers. In families AB.Paris3 and AB.Frei2, two af-
fected siblings shared the same haplotypes. The haplo-
types constructed for these pedigrees suggested linkage
between antenatal Bartter syndrome and the NKCC2
locus (fig. 1).
Characterization of NKCC2 Isoforms
Sequencing of a cDNA, obtained by reverse transcrip-
tion–PCR from kidney RNA of an affected fetus who
died in utero (family AB.Paris9), and of a human cDNA
clone (isolated by screening of a human kidney cDNA
library with a rat cDNA sequence) showed various se-
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Figure 1 Pedigrees and haplotypes of antenatal Bartter syndrome families with linkage to the chromosome 15 NKCC2 interval. Boxes
denote regions of homozygosity for marker alleles. The NKCC2 gene is localized between markers D5S132 and D15S209.
quences at the level of exon 4 (data no shown), raising
the possibility of the existence of three isoforms, as al-
ready detected in other species. To clarify whether this
was the case, the genomic DNA between exon 3 and
exon 5 was amplified by use of a sense primer in exon
3 and an antisense primer in exon 5. The LR-PCR am-
plification product obtained with these primers was∼8.2
kb in size. Direct sequencing and successive database
screens of such products showed, in addition to the exon
4 isoform amplified with primers described by Simon et
al. (1996a) (which is highly homologous to rabbit, rat,
and mouse B isoforms), two alternative exon 4 isoforms,
96 bp in size, that were homologous to the A and F
isoforms of these species. Therefore, three isoforms seem
to be arising from alternative splicing in the human gene.
The order of these cassette exons in genomic DNA is
B–A–F. Figure 2 shows the alignment of the deduced
amino acid sequences encoded by this 96-bp region from
mouse, rat, rabbit, and man. The human amino acid
sequences of isoforms A and F are exactly the same as
the mouse sequences. It is noteworthy that the nucleotide
sequence of exon 4 described by Simon et al. (1996a)
differs from the three isoforms presented here, and we
could not find this sequence in the 8.2-kb genomic-DNA
sequence located between exons 3 and 5. The nucleotide
sequences of three isoforms and the adjacent intronic
sequences have been submitted to the GenBank/EMBL
Data Bank, with accession number AJ005331-3.
Mutation Analysis of the NKCC2 Gene
Sets of primers designed from intronic sequences of
NKCC2 (Simon et al. 1996a), as well as sets of primers
chosen for the additional isoforms of exon 4, were used
to amplify the coding sequence from genomic DNA of
affected individuals. The amplified products were ana-
lyzed by SSCP. Aberrant SSCP patterns were detected in
eight different exons. The affected children in the con-
sanguineous families were homozygous for these
aberrations.
In total, 14 mutations were identified in this cohort
of antenatal Bartter syndrome patients, and 7 of them
were manifested in the homozygous state. Patients
AB.Paris1 and AB.Marb3 have the same mutation. Two
patients (AB.Paris3 and AB.Marb.8) were compound
heterozygotes. In four patients, only one heterozygous
mutation was found (table 2). Sequence analysis revealed
that these mutations are evenly distributed throughout
the NKCC2 gene (fig. 3). In mutation del526N, a 3-bp
deletion causes an in-frame deletion of residue 526,
which is highly conserved in rabbit, rat, and mouse
NKCC2 sequences and in shark NKCC1 sequence.
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Figure 2 A, Genomic organization of the three exon 4 isoforms
(4B, 4A, and 4F). The vertical lines denote the coding exons, and the
thin horizontal line depicts intronic sequences. B, Amino acid sequence
alignment of the ABF cassette of exon 4 from man, rabbit, rat, and
mouse. Double vertical lines denote positions of amino acids that are
not identical in different species. The position of the second trans-
membrane domain is shown (underlined).
Figure 3 Model of NKCC2 cotransporter-protein topology and
position of mutations identified in antenatal Bartter syndrome patients.
One mutation identified in a patient with classic Bartter syndrome is
also indicated (boxed).
Y998X is a nonsense mutation that would lead to a
protein lacking the C-terminal 101 residues of the co-
transporter protein. In mutation 2135–2136delA, a 1-
bp deletion causes a frameshift that does not introduce
a stop codon but that modifies the reading frame from
codon 706 onward. In mutation 1195delT, a 1-bp de-
letion causes a frameshift that would result in a trun-
cated protein of 659 amino acids. Ten mutations are
missense, causing substitutions of residues that are all
highly conserved in rabbit, rat, and mouse NKCC2 se-
quences and in shark NKCC1 sequence.
On the other hand, after our cohort of 31 classic Bart-
ter syndrome patients was screened by SSCP, only one
missense mutation in isoform B of exon 4 was found,
in a patient with a mild phenotype. This is a boy born
at term without polyhydramnios, presenting hypoka-
lemic alkalosis, hyperreninemic hyperaldosteronism,
and hypercalciuria without nephrocalcinosis. This pa-
tient was heterozygous for a CGTrGTA transition at
nucleotide 690, which resulted in the substitution of a
glycine by an aspartic acid at position 224 (G224D).
Exon 4 encodes for TM2, one of the TM domains that
displays only a low identity among the different NKCC
proteins, so that glycine 224 is conserved only in rabbit-
NKCC2 isoform-B protein. No other mutation was
found in other NKCC2 exons of this patient. None of
these aberrant SSCP patterns has been observed in ex-
amination of x50 normal unrelated Caucasian controls
(100 test alleles). A silent change generated by a single
base substitution (GCGrGCA) at nucleotide 2258
(A752A) was found in patient AB.Paris8.
When DNA was available, familial segregation of mu-
tations was shown. The parents in consanguineous fam-
ilies were shown to be heterozygous for the same mu-
tation, and the parents of compound heterozygotes were
heterozygous for one of the two mutations. Two ex-
amples are shown in figure 4.
Discussion
In the normal nephron, the TAL reabsorbs 30% of
the filtered NaCl load (Greger 1985). A primary defect
in TAL chloride transport could explain the constellation
of features evident in Bartter syndrome. Defective TAL
chloride transport would result in markedly increased
NaCl delivery to the distal nephron, with consequent
salt wasting, volume contraction, and stimulation of the
renin-angiotensin-aldosterone axis. Increased distal
reabsorption via the epithelial sodium channel, coupled
with the corresponding increase in potassium and hy-
drogen secretion in the collecting tubule, would cause
hypokalemic metabolic alkalosis. Hypokalemia, chronic
volume contraction, and elevated levels of angiotensin
stimulate PGE2 production (Zusman and Keiser 1977,
1980). Elevated PGE2 inhibits NaCl reabsorption in
TAL and stimulates renin production. Suppression of
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Table 2
Mutations in the Human NKCC2 Gene in Antenatal Bartter Syndrome
Patient Ethnic Origin
Homozygous
Mutation Nucleotidea Consequence Exon
AB.Marb1 Germany R302Q CGGrCAG at 924 ArgrGln at 302 6
AB.Paris9 Mali G319R GGArAGA at 974 GlyrArg at 319 6
AB.Marb7 Yugoslavia 1195delT delT at 1195 Frameshift stop at 1318 8
AB.Paris1 Morocco A508T GCCrACC at 1541 AlarThr at 508 11
AB.Marb6 Germany A510D GCCrGAC at 1548 AlarAsp at 510 11
AB.Paris8 Algeria 2135–2136delA delA at 2135/2136 Frameshift at codon 706 16
AB.Frei1 Turkey del526N del at 1595–1597 delN526 12
Heterozygous
Mutation
AB.Paris3 France G193R GGArAGA at 596 GlyrArg at 193 3
A267S GCTrTCT at 818 AlarSer at 267 5
AB.Frei2 Belgium G243E GGGrGAG at 747 GlyrGlu at 243 5
AB.Marb8 Germany C436Y TGTrTAT at 1326 CysrSer at 436 10
R199G CGCrGGC at 614 ArgrGly at 199 3
AB.Marb10 Italy G478R GGGrAGG at 1451 GlyrAla at 478 10
AB.Marb9 Germany A508T GCCrACC at 1541 AlarThr at 508 11
AB.Marb11 Estonia Y998X TATrTAG at 3013 TyrrStop at 998 24
a Numbering is according to the sequence numbering of GenBank entry U58130; it corresponds to the
nucleotide position plus 19 bases.
Figure 4 Segregation of mutations in the NKCC2 gene in two
families. In family AB.Paris9, the patient and fetus are homozygous,
and their parents are heterozygous, for the mutation. In family
AB.Frei2, two siblings and their father are heterozygous for the
mutation.
PGE2 formation with cyclo-oxygenase inhibitors such
as indomethacin ameliorates many of the clinical and
biochemical abnormalities in Bartter syndrome. Until
now, the mutations in genes that code for three molecules
involved in transepithelial chloride transport across the
TAL have been demonstrated: (1) the Na-K-2Cl cotrans-
porter, the major protein involved in salt reabsorption;
(2) the potassium-channel ROMK, which recycles po-
tassium back into the lumen and is critical for Na-K-
2Cl activity; and (3) the basolateral chloride channel
responsible for basolateral exit of chloride.
This study reports the identification of 14 different
novel mutations in the NKCC2 gene in 13 families of
different ethnic origin that have the antenatal variant of
Bartter syndrome. As a group, the mutations reported
here lead to either the absence or a dramatic alteration
of the protein product. Among the missense mutations,
all causing substitution in residues highly conserved
among species, 8 of 10 are located either inside the trans-
membrane domains or in the first two amino acids of
the subsequent loop. The transmembrane domains show
a very high (175%) sequence identity between the dif-
ferent NKCC proteins, consistent with the importance
of these segments in ion translocation (Payne and For-
bush 1995). Although we screened all NKCC2 exons by
SCCP, in four patients we identified only one hetero-
zygous disease-causing mutation. Although SCCP
screening in this cohort resulted in a mutation-detection
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Figure 5 Schematic diagram of nephron segments. C  cortex;
OM  outer medulla; IM  inner medulla; and MD  macula densa
(other abbreviations are as given in the text). In the TAL in the species
studied, the potential high-capacity, low-affinity Na-K-2Cl cotrans-
porter (isoforms A and F) is localized in the MTAL, and the potential
low-capacity, high-affinity Na-K-2Cl cotransporter (isoform B) is lo-
calized in the CTAL.
rate of 79%, this methodology has well-documented
limitations in sensitivity (Knebelmann et al. 1996). This
probably explains our failure to find the second muta-
tion in the four patients. It is notable that all four pa-
tients were screened for mutations in KCNJ1 and
CLCNKB and that no mutations were found in these
genes. Our data add novel mutations to the six previ-
ously described by Simon et al. (1996a), confirming that
mutations in the bumetanide-sensitive Na-K-2Cl co-
transporter underlie the pathogenesis of antenatal Bart-
ter syndrome.
Contrary to the phenotypes observed in patients with
mutations in the CLCNKB gene, the phenotypes of all
of the present cohort are similar, with polyhydramnios
and prematurity, severe salt wasting during the neonatal
period, severe hypercalciuria, and development of ne-
phrocalcinosis. Furthermore, the available clinical data
on these patients are indistinguishable from those for
our cohort with KCJN1 mutations (The International
Collaborative Study Group for Bartter-Like Syndromes
1997).
The identification of alternative human isoforms of
NKCC2 is a very interesting observation, which could
have important physiological implications. These iso-
forms arise from alternative splicing of three cassettes
of exon 4, resulting in a variable 96-bp sequence that
codes for most of TM2, as well as for 11 amino acids
predicted to be intracellular (Payne and Forbush 1994).
These three isoforms have differential nephron locali-
zation in the species studied. In rabbit, isoform B is al-
most exclusively expressed in the cortex, isoform F is
almost exclusively expressed in the medulla, and isoform
A is approximately equally distributed between those
two regions (Payne and Forbush 1994). In mouse, iso-
form B was most highly expressed in the cortical TAL
(CTAL), isoform F was most highly expressed in the
inner stripe of the outer medulla, and isoform A was
most highly expressed in the outer stripe of the outer
medulla (Igarashi et al. 1995). Finally, in rat, isoform B
is detected exclusively in the CTAL and the macula
densa–containing segments (MDCS), isoform F is ex-
pressed only in the medullary TAL (MTAL) and the
outer-medullary collecting duct, and isoform A is ex-
pressed in the CTAL, the MDCS, and the MTAL (Yang
et al. 1996). This differential nephron localization may
suggest that each isoform is associated with a specific
physiological role. Previous studies have shown differ-
ences in transport of salt and ammonium between the
CTAL and the MTAL, with the MTAL having a higher
net transport rate in mouse, rat, and rabbit (Good et al.
1984; Winters et al. 1991). This difference may be the
consequence of differential isoform localization. This
idea is also supported by data that suggest that the pu-
tative TM2 region (which differs between the splice var-
iants) may be involved in ion binding and ion-affinity
determination. As proposed by Payne and Forbush
(1995), the NKCC2 splice variants may represent a high-
capacity, low-affinity cotransporter in the MTAL (iso-
forms A and F), followed by a low-capacity, high-affinity
cotransporter in the CTAL (isoform B) (fig. 5).
The exact localization of NKCC2 isoforms in man is
not known, but the high homology with the other species
suggests a similar physiological role, and mutations in
the low-capacity, high-affinity isoform (isoform B) might
explain some of the mild phenotypes of Bartter syn-
drome. However, after our cohort of Bartter syndrome
patients was screened by SSCP, only one heterozygous
mutation in isoform B of exon 4 was found, in a patient
with a mild phenotype in whom no mutations in the
CLCNKB gene were found. Functional studies will be
required, to establish the involvement of this mutation
in the pathogenesis of classic Bartter syndrome.
In summary, we have identified 14 novel mutations in
the human NKCC2 gene in patients with the antenatal
variant of Bartter syndrome. These findings confirm and
extend the initial report by Simon et al. (1996a), which
identified NKCC2 as a disease-susceptibility gene in
these patients. In addition, we have identified alternative
isoforms of human NKCC2. In situ hybridization studies
will be necessary to determine the nephron-segment lo-
calization of the three human isoforms of the Na-K-2Cl
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cotransporter. However, in view of data from other
mammalian species that demonstrate differential ex-
pression of these isoforms along the distal nephron, our
data suggest that mutations involving these human iso-
forms may cause disease of varying severity.
Acknowledgments
The authors are indebted to the participating patients and
their families, for their cooperation. We would like to thank
R. Beetz, E. Bonzel, W. Proesmans, R. Topaloglu, and P. Niau-
det, for the contribution of patient material. We thank Dr.
Eileen Boye, for critical reading of the manuscript. M.K. and
H.W.S. were supported by Deutsche Forschungsgemeinschaft
grant Se263/15-1. F.H. and M.V. are additionally supported
by Zentrum Klinische Forschung, Freiburg, Germany. The col-
laborative study group is supported by a Concerted Action,
“Identification of the gene defects in Bartter syndrome and
Gitelman syndrome,” funded by the European Economic Com-
munity, within BIOMED II program PL950260. This study
was performed in cooperation with the International Study of
Genetic Renal Disease.
Electronic-Database Information
Accession numbers and URLs for data in this article are as
follows:
GenBank, http://www.ncbi.nlm.nih.gov/Web/Genbank (for
isoforms A, B, and F and adjacent intronic sequences
[AJ005331-3])
References
Bartter FC, Pronove P, Gill JR, MacCardle RC (1962) Hy-
perplasia of the juxtaglomerular complex with hyperaldoste-
ronism and hypokalemic alkalosis: a new syndrome. Am J
Med 33:811–828
Deschenes G, Burguet A, Guyot C, Hubert P, Garabedian M,
De´chaux M, Loirat C, et al (1993) Forme ante´natale du
syndrome de Bartter. Ann Pediatr 40:95–101
Fanconi A, Schachenmann G, Nussli R, Prader A (1971)
Chronic hypokalemia with growth retardation, normoten-
sive hyperrenin-hyperaldosteronism (Bartter’s syndrome)
and hypercalciuria. Helv Pediatr Acta 26:144–163
Gitelman HJ, Graham JB, Welt LG (1966) A new familial
disorder characterized by hypokalemia and hypomagnese-
mia. Trans Assoc Am Physicians 79:221–235
Good DW, Knepper MA, Burg MB (1984) Ammonia and bi-
carbonate transport by thick ascending limb of rat kidney.
Am J Physiol 247:F35–F44
Greger R (1985) Ion transport mechanism in thick ascending
limb of Henle’s loop of mammalian nephron. Physiol Rev
65:760–797
Hiort O, Wedtke A, Zollmer A, Sinneckes G (1994) Detection
of point mutations in the androgen receptor gene using non-
isotopic single strand conformation polymorphism analysis.
Hum Mol Genet 3:1163–1166
Hogewind B, Van Brummelen P, Veltkamp J (1981) Bartter’s
syndrome: an autosomal recessive disorder? study of four
patients in one generation of the same pedigree and their
relatives. Acta Med Scand 209:463–467
Igarashi P, Vanden Heuvel GB, Payne JA, Forbush B (1995)
Cloning, embryonic expression, and alternative splicing of
a murine kidney-specific Na-K-Cl cotransporter. Am J Phy-
siol 269:F405–F418
International Collaborative Study Group for Bartter-Like Syn-
dromes, The (1997) Mutations in the gene encoding the
inwardly-rectifying renal potassium channel, ROMK, cause
the antenatal variant of Bartter syndrome: evidence for ge-
netic heterogeneity. Hum Mol Genet 6:17–26
Knebelmann B, Breillat C, Forestier L, Arrondel C, Jacassier
D, Giatras I, Drouot L, et al (1996) Spectrum of mutations
in the COL4A5 collagen gene in X-linked Alport syndrome.
Am J Hum Genet 59:1221–1232
Knebelmann B, Deschenes G, Gros F, Hors M-C, Gru¨nfeld J-
P, Tryggvason K, Gubler M-C, et al (1992) Substitution of
arginine for glycine 325 in the collagen a5(IV) chain asso-
ciated with X-linked Alport syndrome: characterization of
the mutation by direct sequencing of PCR-amplified lym-
phoblast cDNA fragments. Am J Hum Genet 51:135–142
Ko¨ckerling A, Reinalter S, Seyberth H (1996) Impaired re-
sponse to furosemide in hyperprostaglandin E syndrome:
evidence for a tubular defect in the loop of Henle. J Pediatr
129:519–528
Leonhardt A, Timmermanns G, Roth B, Seyberth H (1992)
Calcium homeostasis and hypercalciuria in hyperprostag-
landin E syndrome. J Pediatr 120:546–554
McCredie DA, Rotenberg E, Williams AL (1974) Hypercal-
ciuria in potassium-losing nephropathy: a variant of Bart-
ter’s syndrome. Aust Paediatr J 10:286–295
Ohlsson A, Sieck U, Cumming W, Akhtar M, Serenius F (1984)
Bartter syndrome associated with hydramnios prematurity,
hypercalciuria and nephrocalcinosis. Acta Pediatr Scand 73:
868–874
Orita M, Suzuki YH, Sakiya T, Hayaski K (1989) Rapid and
sensitive detection of point mutations and DNA polymor-
phisms using the polymerase chain reaction. Genomics 5:
874–879
Payne JA, Forbush B (1994) Alternatively spliced isoforms of
the putative renal Na-K-Cl cotransporter are differentially
distributed within the rabbit kidney. Proc Natl Acad Sci USA
91:4544–4548
——— (1995) Molecular characterization of the epithelial
Na-K-Cl cotransporter isoforms. Curr Opin Cell Biol 7:
493–503
Proesmans W, Devlieger H, Assche AV, Eggermont E, Van-
denberghe K, Lemmens F, Sieprath P, et al (1985) Bartter
syndrome in two siblings—antenatal and neonatal obser-
vations. Int J Pediatr Nephrol 6:63–70
Reed PW, Davies JL, Copeman JB, Bennet ST, Palmer SM,
Pritchard LE, Gough SLC, et al (1994) Chromosome-specific
microsatellite sets for fluorescence-based, semi-automated
genome mapping. Nat Genet 7:390–395
Rozet JM, Gerber S, Perrault I, Camuzat A, Calvas P, Viegas-
Pequinot E, Molina-Gomes D, et al (1996) Structure and
physical mapping of DR1, a TATA-binding protein-associ-
ated phosphoprotein gene, to chromosome 1p22.1 and its
1340 Am. J. Hum. Genet. 62:1332–1340, 1998
exclusion in Stargardt disease (STGD). Genomics 36:
554–556
Schwartz I, Alon U (1996) Bartter syndrome revisited. J Ne-
phrol 9:81–87
Seyberth HW, Ko¨niger SJ, Rascher W, Ku¨hl PG, Schweer H
(1987) Role of prostaglandins in hyperprostaglandin E syn-
drome and in selected renal tubular disorders. Pediatr Ne-
phrol 1:491–497
Seyberth HW, Rascher W, Schweer H, Kuhl P, Mehls O,
Scha¨rer K (1985) Congenital hypokalemia with hypercal-
ciuria in preterm infants: a hyperprostaglandinuric tubular
syndrome different from Bartter syndrome. J Pediatr 107:
694–701
Shizuya H, Birren B, Kim UJ, Mancino V, Splepak T, Tachiiri
Y, Simon M (1992) Cloning and stable maintenance of 300-
kb fragments of human DNA in Escherichia coli using F-
factor-based vector. Proc Natl Acad Sci USA 89:8794–8797
Shoemaker L, Welch T, Bergstrom W, Abrams S, Yergey A,
Vieira N (1993) Calcium kinetics in the hyperprostaglandin
E syndrome. Pediatr Res 33:92–96
Simon D, Bindra RS, Mansfield TA, Nelson-Williams C, Men-
doca E, Stone R, Schurman S, et al (1997) Mutations in the
chloride channel gene, CLCNKB, cause Bartter’s syndrome
type III. Nat Genet 17:171–178
Simon D, Karet F, Hamdan J, DiPetro A, Sanjad S, Lifton R
(1996a) Bartter’s syndrome, hypokalemic alkalosis with hy-
percalciuria, is caused by mutations in the Na-K-2Cl co-
transporter NKCC2. Nat Genet 13:183–188
Simon D, Karet F, Rodriguez-Soriano J, Hamdan J, DiPietro
A, Trachtman H, Sanjad S, et al (1996b) Genetic hetero-
geneity of Bartter’s syndrome revealed by mutations in the
K channel, ROMK. Nat Genet 14:152–156
Winters CJ, Reeves WB, Andreoli TE (1991) A survey of trans-
port properties of the thick ascending limb. Semin Nephrol
11:236–247
Wippermann CF, Huber A, Beetz R, Baum V, Stopfkuchen H
(1993) Polyhydramnios caused by fetal hyperprostaglandin
E syndrome, a variant of Bartter’s syndrome: case report
and review of the literature. J Matern Fetal Invest 3:91–93
Yang T, Huang YG, Singh I, Schnermann J, Briggs JP (1996)
Localization of bumetanide- and thiazide-sensitive Na-K-Cl
cotransporters along the rat nephron. Am J Physiol 271:
F931–F939
Zusman R, Keiser H (1977) Prostaglandin biosynthesis by rab-
bit renomedullary interstitial cells in tissue culture: stimu-
lation by angiotensin II, bradykinin and arginine vasopres-
sin. J Clin Invest 60:215–223
——— (1980) Regulation of prostaglandin E2 synthesis by
angiotensin II, potassium, osmolality, and dexamethasone.
Kidney Int 17:277–283
